Pill vs. IV drip: new hope for blood disorder patients

This study is testing if a new oral pill (ASTX727) works as well as the standard intravenous (IV) drug (decitabine) for people with myelodysplastic syndromes (MDS), a serious disorder where the bone marrow doesn't make enough healthy blood cells. Researchers will compare how the body processes each drug and check if the pill can control the disease, reduce the need for blood transfusions, and delay progression. The goal is to see if the pill offers a more convenient treatment option with similar benefits.